Dynamic glucose-enhanced deuterium MRS (DGE 2H-MRS) coupled with Marchenko-Pastur PCA denoising has shown potential for in vivo quantification of glucose metabolism through glycolysis and mitochondrial oxidation in a mouse model of glioblastoma, and for assessment of pathway flux modulations according to tumor heterogeneity. Here, we extend this approach to immunocompetent mouse glioblastoma subtypes with marked differences in tumor cell metabolism and histopathologic features, to utterly demonstrate the potential of DGE 2H-MRS for non-invasive metabolic phenotyping of glioma, or other cancers with mitochondrial oxidation dependencies, according to key features of the tumor microenvironment such as cell proliferation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords